Surfactant protein A detection in primary pulmonary adenocarcinoma without bronchioloalveolar pattern

Respiration

Volumn 72, Issue 3, 2005, Pages 249-253

  Uzaslan, Esra ^a   Stuempel, Tina ^a   Ebsen, Michael ^a   Freudenberg, Nikolaus ^b   Nakamura, Shinobu ^d   Costabel, Ulrich ^c   Guzman, Josune ^a,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c RUHRLANDKLINIK   (Germany)

^d NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adenocarcinoma of the lung; Immunohistochemistry; Surfactant protein A

Indexed keywords

SURFACTANT PROTEIN A;

ACINAR CELL CARCINOMA; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STAINING; TUMOR CELL; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; CARCINOMA, ACINAR CELL; HUMANS; LUNG NEOPLASMS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; TUMOR MARKERS, BIOLOGICAL;

EID: 22144432301     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085365     Document Type: Article

References (22)

1. Zamecnik J, Kodet R: Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: A study of 109 cases. Virchows Arch 2002;440:353-361.
2. Ueno T, Linder S, Elmberger G: Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer 2003;88:1229-1233.
3. Singh G, Scheithauer BW, Katyal SL: The pathobiologic features of carcinomas of type II pneumocytes. An immunocytologic study. Cancer 1986;57:994-999.
4. Chieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT: Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001;93:330-336.
5. Linnoila RI, Jensen SM, Steinberg SM, Mulshine JL, Eggleston JC, Gazdar AF: Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features. Am J Clin Pathol 1992;97:233-243.
6. Komatsu H, Katayama T, Murakami K, Sagara Y, Hayashi K: Immunohistochemical study of lung cancer using monoclonal antibody against human pulmonary surfactant apoprotein. Nippon Kyobu Geka Gakkai Zasshi 1991;39:2172-2175.
7. Mizutani Y, Nakajima T, Morinaga S, Gotoh M, Shimosato Y, Akino T, Suzuki A: Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Special reference to nonmucus producing lung adenocarcinomas. Cancer 1988;61:532-537.
8. Ten Have-Opbroek AA, Benfield JR, van Krieken JH, Dijkman JH: The alveolar type II cell is a pluripotential stem cell in the genesis of human adenocarcinomas and squamous cell carcinomas. Histol Histopathol 1997;12:319-336.
9. Linnoila RI, Mulshine JL, Steinberg SM, Gazdar AF: Expression of surfactant-associated protein in non-small-cell lung cancer: A discriminant between biologic subsets. J Natl Cancer Inst Monogr 1992;13:61-66.
10. Kitinya JN, Sueishi K, Tanaka K, Katsuda Y: Immunoreactivity of surfactant-apoprotein in adenocarcinomas, large cell and small cell carcinomas of the lung. Acta Pathol Jpn 1986;36:1271-1278.
11. Kaufmann O, Dietel M: Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology 2000;36:8-16.
12. Gazdar AF, Linnoila RI, Kurita Y, Oie HK, Mulshine JL, Clark JC, Whitsett JA: Peripheral airway cell differentiation in human lung cancer cell lines. Cancer Res 1990;50:5481-5487.
13. Hirata H, Noguchi M, Shimosato Y, Uei Y, Goya T: Clinicopathologic and immunohistochemical characteristics of bronchial gland type adenocarcinoma of the lung. Am J Clin Pathol 1990;93:20-25.
14. Broers JL, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD, Linnoila RI: Expression of surfactant associated protein-A and Clara cell 10 kilo-dalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. Lab Invest 1992;66:337-346.
15. Nicholson AG, McCormick CJ, Shimosato Y, Butcher DN, Sheppard MN: The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours. Histopathology 1995;27:57-60.
16. Sugiyama K, Kawai T, Nakanishi K, Suzuki M: Histochemical reactivities of lectins and surfactant apoprotein in pulmonary adenocarcinomas and their metastases. Mod Pathol 1992;5:273-276.
17. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E: World Health Organisation (WHO) International Histologic Classification of Tumors. Histological Typing of Lung and Pleural Tumors, ed 3. WHO, 1999, pp 54-55.
18. Bross KJ, Pangalis GA, Staatz CG, Blume KG: Demonstration of cell surface antigens and their antibodies by the peroxidase-antiperoxidase method. Transplantation 1978;25:331-334.
19. Guzman J, Wang YM, Kalaycioglu O, Schoenfeld B, Hamm H, Bartsch H, Costabel U: Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis. Acta Cytol 1992;36:668-673.
20. Singh G, Katyal SL, Ordonez NG, Dail DH, Negishi Y, Weedn VW, Marcus PB, Weldon-Linne CM, Axiotis CA, Alvarez-Fernandez E, Smith WI: Type II pneumocytes in pulmonary tumors. Implications for histogenesis. Arch Pathol Lab Med 1984;108:44-48.
21. Silver SA, Askin FB: True papillary carcinoma of the lung: A distinct clinicopathologic entity. Am J Surg Pathol 1997;1:43-51.
22. Ten Have-Opbroek AA, Hammond WG, Benfield JR, Teplitz RL, Dijkman JH: Expression of alveolar type II cell markers in acinar adenocarcinomas and adenoid cystic carcinomas arising from segmental bronchi. A study in heterotopic bronchogenic carcinoma model in dogs. Am J Pathol 1993;142:1251-1264.